Top Markets
#1 Siren Siren +31.61%
#2 OriginTrail OriginTrail +29.02%
#3 Tutorial Tutorial +14.64%
#4 Waves Waves +11.24%
#5 Cortex Cortex +11.09%
#6 Synapse Synapse +10.97%
#7 MarsCoin MarsCoin +9.27%
#8 Pons Pons +8.17%
#9 TROLL TROLL +6.05%
#10 Concordium Concordium +5.93%
Coin of the day
Siren Siren
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Rangering i aksjer #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Aksjekurs
$0.49606484
Sist synkronisert: 2026-08-21
Markedsverdi
$88.47M
Endring (1 dag)
-1.58%
Endring (1 år)
-22.51%
Land
TW
Handel Intech Biopharm Corporation (6461)

Kategori

Healthcare
Inntekter for Intech Biopharm Corporation (6461)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Intech Biopharm Corporation er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Intech Biopharm Corporation fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH